A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria
Conditions: Chronic Kidney Disease; Proteinuria; Children Intervention: Drug: Finerenone (Kerendia, BAY94-8862) Sponsor: Bayer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 13, 2022 Category: Research Source Type: clinical trials
